TrialInternal medicine (Tokyo, Japan)2020

Beneficial Effects of Ipragliflozin on the Renal Function and Serum Uric Acid Levels in Japanese Patients with Type 2 Diabetes: A Randomized, 12-week, Open-label, Active-controlled Trial.

Masashi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.